当前位置:首页 - 行情中心 - 欧康医药(920230) - 财务分析 - 现金流量表

欧康医药

(920230)

  

流通市值:6.88亿  总市值:14.84亿
流通股本:4670.90万   总股本:1.01亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金259,115,711.46170,472,258.2274,009,075.82319,235,679.64
  收到的税费返还3,799,165.511,600,753.061,429,032.257,856,210.51
  收到其他与经营活动有关的现金4,225,521.12,912,458.39274,144.918,966,334.84
  经营活动现金流入小计267,140,398.07174,985,469.6775,712,252.97346,058,224.99
  购买商品、接受劳务支付的现金235,045,144.04135,011,363.2668,600,636.41290,733,509.8
  支付给职工以及为职工支付的现金15,288,466.2210,978,754.98,078,759.0723,397,913.23
  支付的各项税费3,416,280.12,743,230.731,452,866.27,805,991.64
  支付其他与经营活动有关的现金9,908,693.073,479,716.361,165,579.579,672,594.8
  经营活动现金流出小计263,658,583.43152,213,065.2579,297,841.25331,610,009.47
  经营活动产生的现金流量净额3,481,814.6422,772,404.42-3,585,588.2814,448,215.52
二、投资活动产生的现金流量:
  收回投资收到的现金89,174,936.8270,824,474.5733,722,019.27314,866,667.72
  取得投资收益收到的现金418,875.916,650.44,921.43944,982.92
  处置固定资产、无形资产和其他长期资产收回的现金净额117,476.5107,963.72323502,362.52
  收到的其他与投资活动有关的现金20,000---
  投资活动现金流入小计89,731,289.2270,949,088.6933,727,263.7316,314,013.16
  购建固定资产、无形资产和其他长期资产支付的现金17,826,320.0813,316,754.5115,334,735.0989,675,164.16
  投资支付的现金82,336,91566,456,91528,389,330262,954,334
  投资活动现金流出小计100,163,235.0879,773,669.5143,724,065.09352,629,498.16
  投资活动产生的现金流量净额-10,431,945.86-8,824,580.82-9,996,801.39-36,315,485
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,101,600--9,560,809
  其中:子公司吸收少数股东投资收到的现金---710,590
  取得借款收到的现金11,000,00011,000,000-29,000,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计12,101,60011,000,000-38,560,809
  偿还债务支付的现金10,000,00010,000,000-30,000,000
  分配股利、利润或偿付利息支付的现金8,201,956.368,047,313.74159,583.3315,735,637.92
  支付其他与筹资活动有关的现金262,577.17152,941.43130,147.66196,593.12
  筹资活动现金流出小计18,464,533.5318,200,255.17289,730.9945,932,231.04
  筹资活动产生的现金流量净额-6,362,933.53-7,200,255.17-289,730.99-7,371,422.04
四、汇率变动对现金及现金等价物的影响-51,143.591,949.4793,141.3528,985.61
五、现金及现金等价物净增加额-13,364,208.346,749,517.9-13,778,979.36-28,709,705.91
  加:期初现金及现金等价物余额22,811,390.722,811,390.722,811,390.751,521,096.61
  期末现金及现金等价物余额9,447,182.3629,560,908.69,032,411.3422,811,390.7
补充资料:
  净利润-2,867,815.24-22,115,851.18
  资产减值准备--34,835.62-2,605,981.05
  固定资产和投资性房地产折旧-9,586,496.51-7,785,469.36
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,586,496.51-7,785,469.36
  无形资产摊销-334,803.2-573,861.69
  处置固定资产、无形资产和其他长期资产的损失-3,090.12-885,060.79
  公允价值变动损失--306,720.1--226,447.55
  财务费用-314,758.06-384,153.3
  投资损失--43,208.56--944,982.92
  递延所得税-147,551.29--1,743,246.92
  其中:递延所得税资产减少-147,551.29--1,743,246.92
  存货的减少-3,476,576.62--24,736,483.48
  经营性应收项目的减少-30,112,775.47--19,149,973.57
  经营性应付项目的增加--25,718,967.31-23,784,531.53
  其他-1,833,256.58-3,772,856.88
  不涉及现金收支的投资和筹资活动金额其他项目-787,662.57-773,783.6
  现金的期末余额-29,564,912.17-22,811,390.7
  减:现金的期初余额-22,815,394.27-51,521,096.61
  现金及现金等价物的净增加额-6,749,517.9--28,709,705.91
公告日期2025-10-302025-08-272025-04-282025-04-17
审计意见(境内)标准无保留意见
TOP↑